KAMADA
Live / Allowed — Publication / registration review complete (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99182288
- Mark type
- Design + words
- Filed
- 13 May 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Ben Natter
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, plasma derived and recombinant immunoglobulins for use in the treatment of infectious diseases, namely, CMV disease, Hepatitis B, Varicella Zoster, and rabies, Hematologic conditions including Idiopathic Thrombocytopenic Purpura; Respiratory conditions including Alpha-1 Antitrypsin Deficiency, Obstetrics and Gynecology conditions such as hemolytic disease of the newborn, Transplantation treatments including solid-organ transplants and hematopoietic stem-cell transplantation; pharmaceuticals namely plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders and treating inflammatory diseases; pharmaceuticals namely coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thromboembolic disorders; pharmaceutical preparations for anesthesia analgesia for surgery; pharmaceutical preparations for treatment of CMV infection and disease; pharmaceutical preparations for the treatment of Varicella Zoster Virus; pharmaceutical preparations for treatment of Hepatitis; pharmaceutical preparations for the treatment of Rabies
Owner
- Kamada Ltd., Rehovot, IL
Prior registrations
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Mar 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 18 Dec 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 18 Dec 2025 — LETTER OF SUSPENSION E-MAILED
- 18 Dec 2025 — SUSPENSION LETTER WRITTEN
- 12 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Sept 2025 — NON-FINAL ACTION E-MAILED
- 26 Sept 2025 — NON-FINAL ACTION WRITTEN
- 26 Sept 2025 — ASSIGNED TO EXAMINER